Prime Medicine, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Prime Medicine, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q3 2024.
  • Prime Medicine, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 120M shares, a 30.4% increase year-over-year.
  • Prime Medicine, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 91M shares, a 168% increase from 2022.
  • Prime Medicine, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 33.9M shares, a 161% increase from 2021.
  • Prime Medicine, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13M shares, a 391% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 120M +27.9M +30.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 119M +28.7M +31.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 104M +15.4M +17.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 91M +57.1M +168% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 91.8M +69.6M +313% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 90.5M +70.2M +347% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 89.1M +70M +368% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 33.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 22.2M +7.26M +48.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 20.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 19.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 15M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.